Incidence of hepatitis C virus infection in patients on hemodialysis: A systematic review and meta-analysis

Hemodialysis International

Volumn 17, Issue 4, 2013, Pages 532-541

  Su, Yingying ^a   Norris, Jessie L ^a   Zang, Chunpeng ^a   Peng, Zhihang ^b   Wang, Ning ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Epidemiology; HCV; Hemodialysis; Hepatitis C; Nosocomial infection

Indexed keywords

ARTICLE; COHORT ANALYSIS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; META ANALYSIS; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SYSTEMATIC REVIEW;

EPIDEMIOLOGY; HCV; HEMODIALYSIS; HEPATITIS C; NOSOCOMIAL INFECTION;

FEMALE; HEPATITIS C; HUMANS; MALE; PREVALENCE; RENAL DIALYSIS; RISK FACTORS;

EID: 84884987770     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2012.00761.x     Document Type: Article

References (42)

1. Wreghitt TG. Blood-borne virus infections in dialysis units-A review. Rev Med Virol. 1999; 9:101-109.
2. Zamani F, Ameli M, Razmjou S, Shakeri R, Amiri A, Darvish R. Incidence of hepatitis C infection in patients on hemodialysis: A multicenter study of northern part of Iran. Saudi J Kidney Dis Transpl. 2010; 21:1169-1171.
3. Stehman-Breen CO, Emerson S, Gretch D, Johnson RJ. Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis. 1998; 32:629-634.
4. Fissell RB, Bragg-Gresham JL, Woods JD, etal. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS. Kidney Int. 2004; 65:2335-2342.
5. Johnson DW, Dent H, Yao Q, etal. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: Analysis of registry data. Nephrol Dial Transplant. 2009; 24:1598-1603.
6. Pujol FH, Ponce JG, Lema MG, etal. High incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalence. J Clin Microbiol. 1996; 34:1633-1636.
7. Elamin S, Abu-Aisha H. Prevention of hepatitis B virus and hepatitis C virus transmission in hemodialysis centers: Review of current international recommendations. Arab J Nephrol Transplant. 2011; 4:35-47.
8. Saune K, Kamar N, Miedouge M, etal. Decreased prevalence and incidence of HCV markers in haemodialysis units: A multicentric French survey. Nephrol Dial Transplant. 2011; 26:2309-2316.
9. Carneiro MA, Teles SA, Dias MA, etal. Decline of hepatitis C infection in hemodialysis patients in Central Brazil: A ten years of surveillance. Mem Inst Oswaldo Cruz. 2005; 100:345-349.
10. Jadoul M, Poignet JL, Geddes C, etal. The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study. Nephrol Dial Transplant. 2004; 19:904-909.
11. Di Napoli A, Pezzotti P, Di Lallo D, Petrosillo N, Trivelloni C, Di Giulio S. Epidemiology of hepatitis C virus among long-term dialysis patients: A 9-year study in an Italian region. Am J Kidney Dis. 2006; 48:629-637.
12. Espinosa M, Martn-Malo A, Ojeda R, etal. Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients: Causes and consequences. Am J Kidney Dis. 2004; 43:685-689.
13. Bergman S, Accortt N, Turner A, Glaze J. Hepatitis C infection is acquired pre-ESRD. Am J Kidney Dis. 2005; 45:684-689.
14. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. J Clin Epidemiol. 2009; 62:1006-1012.
15. Stroup DF, Berlin JA, Morton SC, etal. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283:2008-2012.
16. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing. 2011; ISBN 3-900051-07-0. Available from: http://www.R-project.org/ (accessed date: October 12, 2011).
17. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-Analysis: Wiley Online Library, 2009.
18. Nemati E, Alavian SM, Taheri S, Moradi M, Pourfarziani V, Einollahi B. Hepatitis C virus infection among patients on hemodialysis: A report from a single center in Iran. Saudi J Kidney Dis Transpl. 2009; 20:147-153.
19. Engel M, Malta FM, Gomes MM, etal. Acute hepatitis C virus infection assessment among chronic hemodialysis patients in the Southwest Parana State, Brazil. BMC Public Health. 2007; 7:50.
20. Prati D, Capelli C, Silvani C, etal. The incidence and risk factors of community-acquired hepatitis C in a cohort of Italian blood donors. Hepatology. 1997; 25:702-704.
21. Okayama A, Stuver SO, Tabor E, etal. Incident hepatitis C virus infection in a community-based population in Japan. J Viral Hepat. 2002; 9:43-51.
22. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005; 5:558-567.
23. Djordjevic V, Stojanovic K, Stojanovic M, Stefanovic V. Prevention of nosocomial transmission of hepatitis C infection in a hemodialysis unit. A prospective study. Int J Artif Organs. 2000; 23:181-188.
24. Patel PR, Thompson ND, Kallen AJ, Arduino MJ. Epidemiology, surveillance, and prevention of hepatitis C virus infections in hemodialysis patients. Am J Kidney Dis. 2010; 56:371-378.
25. Jadoul M, Cornu C, van Ypersele de Strihou C. Universal precautions prevent hepatitis C virus transmission: A 54 month follow-up of the Belgian Multicenter Study. The Universitaires Cliniques St-Luc (UCL) Collaborative Group. Kidney Int. 1998; 53:1022-1025.
26. Moreira R, Pinho JR, Fares J, etal. Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies. Can J Microbiol. 2003; 49:503-507.
27. Shamshirsaz AA, Kamgar M, Bekheirnia MR, etal. The role of hemodialysis machines dedication in reducing hepatitis C transmission in the dialysis setting in Iran: A multicenter prospective interventional study. BMC Nephrol. 2004; 5:1-5.
28. Fabrizi F, Lunghi G, Guarnori I, etal. Incidence of seroconversion for hepatitis C virus in chronic haemodialysis patients: A prospective study. Nephrol Dial Transplant. 1994; 9:1611-1615.
29. Niu MT, Coleman PJ, Alter MJ. Multicenter study of hepatitis C virus infection in chronic hemodialysis patients and hemodialysis center staff members. Am J Kidney Dis. 1993; 22:568-573.
30. Fabrizi F, de Vecchi AF, Como G, Lunghi G, Martin P. De novo HCV infection among dialysis patients: A prospective study by HCV core antigen ELISA assay. Aliment Pharmacol Ther. 2005; 21:861-869.
31. Kumagai J, Komiya Y, Tanaka J, etal. Hepatitis C virus infection in 2, 744 hemodialysis patients followed regularly at nine centers in Hiroshima during November 1999 through February 2003. J Med Virol. 2005; 76:498-502.
32. Sypsa V, Psichogiou M, Katsoulidou A, etal. Incidence and patterns of hepatitis C virus seroconversion in a cohort of hemodialysis patients. Am J Kidney Dis. 2005; 45:334-343.
33. Jadoul M, Cornu C, van Ypersele de Strihou C. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: A prospective study. The UCL Collaborative Group. Kidney Int. 1993; 44:1322-1326.
34. Izopet J, Sandres-Saune K, Kamar N, etal. Incidence of HCV infection in French hemodialysis units: A prospective study. J Med Virol. 2005; 77:70-76.
35. Santos MA, Souto FJ. Infection by the hepatitis C virus in chronic renal failure patients undergoing hemodialysis in Mato Grosso state, central Brazil: A cohort study. BMC Public Health. 2007; 7:32.
36. Biamino E, Caligaris F, Ferrero S, Montalcini G, Bongiorno P, Scuvera I. Prevalence of anti-HCV antibody positivity and seroconversion incidence in hemodialysis patients. Minerva Urol Nefrol. 1999; 51:53-55.
37. Tu AW, Buxton JA, Whitlock M, etal. Prevalence and incidence of hepatitis C virus in hemodialysis patients in British Columbia: Follow-up after a possible breach in hemodialysis machines. Can J Infect Dis Med Microbiol. 2009; 20:e19-e23.
38. Kobayashi M, Tanaka E, Oguchi H, Hora K, Kiyosawa K. Prospective follow-up study of hepatitis C virus infection in patients undergoing maintenance haemodialysis: Comparison among haemodialysis units. J Gastroenterol Hepatol. 1998; 13:604-609.
39. Fabrizi F, Martin P, Dixit V, etal. Acquisition of hepatitis C virus in hemodialysis patients: A prospective study by branched DNA signal amplification assay. Am J Kidney Dis. 1998; 31:647-654.
40. Furusyo N, Hayashi J, Kakuda K, etal. Acute hepatitis C among Japanese hemodialysis patients: A prospective 9-year study. Am J Gastroenterol. 2001; 96:1592-1600.
41. Schneeberger PM, Keur I, van Loon AM, etal. The prevalence and incidence of hepatitis C virus infections among dialysis patients in the Netherlands: A nationwide prospective study. J Infect Dis. 2000; 182:1291-1299.
42. Petrosillo N, Gilli P, Serraino D, etal. Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis. 2001; 37:1004-1010.